[1]
Xu, H., Wang, D., Ramponi, C., Wang, X. and Zhang, H. 2022. The P21-Activated Kinase 1 and 2 As Potential Therapeutic Targets for the Management of Cardiovascular Disease. International Journal of Drug Discovery and Pharmacology. 1, 1 (Dec. 2022), 5. DOI:https://doi.org/10.53941/ijddp.v1i1.179.